Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)

Schimanski, CC; Kasper, S; Hegewisch-Becker, S; Schroder, J; Overkamp, F; Kullmann, F; Bechstein, WO; Vohringer, M; Ollinger, R; Lordick, F; Heinemann, V; Geissler, M; Schulz-Abelius, A; Bernhard, H; Schon, MR; Greil, R; Galle, P; Lang, H; Schmidtmann, I; Moehler, M

View this publication in the PUBMED database